INFLUENCE OF SOME DOPAMINERGIC AGENTS ON ANTINOCICEPTION PRODUCED BY QUININE IN MICE

被引:1
作者
AMABEOKU, G [1 ]
EWESUEDO, R [1 ]
ABUH, F [1 ]
机构
[1] AHMADU BELLO UNIV, FAC PHARMACEUT SCI, DEPT PHARMACOL & CLIN PHARMACOL, ZARIA, NIGERIA
关键词
ANTINOCICEPTION; DOPAMINERGIC MECHANISM; MICE; QUININE; TAIL-IMMERSION TEST;
D O I
10.1016/0278-5846(92)90086-T
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. The analgesic effect of quinine and the influence of some dopaminergic agents on it were studied in mice. 2. Quinine (25-130mg/kg, ip) effectively elicited antinociceptive effect in a dose related manner. 3. D-Amphetamine (2.5-4mg/kg, ip), L-dopa (25mg/kg, sc), L-dopa (25mg/kg, sc) plus benserazide (12.5mg/kg, sc), alpha-methyl-p-tyrosine (50mg/kg, ip) plus L-dopa (25mg/kg, sc) and pargyline (50mg/kg, ip) significantly attenuated the antinociceptive effect of quinine (50mg/kg, ip), while DOPS (4mg/kg, ip) did not affect quinine antinociception. 4. Pimozide (4mg/kg, ip), L-sulpiride (40mg/kg, ip), SCH 23390 (0.2mg/kg, sc) and alpha-methyl-p-tyrosine (50mg/kg, ip) effectively potentiated the antinociceptive effects of quinine (50mg/kg, ip). 5. Pimozide (4mg/kg, ip) also antagonised the antagonistic effect of d-amphetamine (4mg/kg, ip) on the antinociceptive effect of quinine (50mg/kg, ip). 6. These data indicate that quinine elicited antinociception dose dependently. Furthermore, the influence of pimozide, L-sulpiride and SCH 23390 on quinine antinociception suggests the involvement of dopaminergic mechanisms.
引用
收藏
页码:351 / 360
页数:10
相关论文
共 32 条
  • [11] L-DOPA AND IMIPRAMINE - BIOCHEMICAL AND BEHAVIORAL INTERACTION
    FRIEDMAN, E
    GERSHON, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 18 (02) : 183 - &
  • [12] BEHAVIORAL CORRELATIONS OF DOPAMINE RECEPTOR ACTIVATION
    GERSHANIK, O
    HEIKKILA, RE
    DUVOISIN, RC
    [J]. NEUROLOGY, 1983, 33 (11) : 1489 - 1492
  • [13] GLOCK D, 1981, FED PROC, V40, P290
  • [14] GONZALEZ JP, 1985, BR J PHARM P S, V86, P709
  • [15] BENSERAZIDE AND CARBIDOPA AS SUBSTRATES OF CATECHOL-O-METHYLTRANSFERASE - NEW MECHANISM OF ACTION IN PARKINSONS-DISEASE
    HAGAN, RM
    RAXWORTHY, MJ
    GULLIVER, PA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (23) : 3123 - 3126
  • [16] TREATMENT OF SEVERE FALCIPARUM-MALARIA
    HALL, AP
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1977, 71 (05) : 367 - 379
  • [17] TREATMENT OF MALARIA
    HALL, AP
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1976, 1 (6005): : 323 - 328
  • [18] IORIO LC, 1981, J PHARMACOL EXP THER, V217, P451
  • [19] JONGH DK, 1952, ARCH INT PHARMACOD T, V90, P449
  • [20] JONGH DK, 1952, ARCH INT PHARMACOD T, V90, P466